Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors.

Serpico D, Trama A, Haspinger ER, Agustoni F, Botta L, Berardi R, Palmieri G, Zucali P, Gallucci R, Broggini M, Gatta G, Pastorino U, Pelosi G, de Braud F, Garassino MC; TYME (TYmic MalignanciEs) Collaborative Group.

Ann Oncol. 2015 May;26(5):838-47. doi: 10.1093/annonc/mdu527. Epub 2014 Nov 19. Review.

2.

Genetic profiling of thymic carcinoma using targeted next-generation sequencing.

Shitara M, Okuda K, Suzuki A, Tatematsu T, Hikosaka Y, Moriyama S, Sasaki H, Fujii Y, Yano M.

Lung Cancer. 2014 Nov;86(2):174-9. doi: 10.1016/j.lungcan.2014.08.020. Epub 2014 Sep 10.

PMID:
25249426
3.

Immunohistochemical analysis of thymic carcinoma focusing on the possibility of molecular targeted and hormonal therapies.

Omatsu M, Kunimura T, Mikogami T, Hamatani S, Shiokawa A, Masunaga A, Kitami A, Suzuki T, Kadokura M, Morohoshi T.

Gen Thorac Cardiovasc Surg. 2012 Dec;60(12):803-10. doi: 10.1007/s11748-012-0160-x. Epub 2012 Oct 3.

PMID:
23054618
4.

Insulin-like growth factor-1 receptor expression in thymic malignancies.

Girard N, Teruya-Feldstein J, Payabyab EC, Riely GJ, Rusch VW, Kris MG, Zakowski MF.

J Thorac Oncol. 2010 Sep;5(9):1439-46. doi: 10.1097/JTO.0b013e3181e392a8.

5.

Fibrous pleural tumor with hypoglycemia: case study.

Adhami N, Ahmed R, Lento PA, Shimshi M, Herman SD, Teirstein AS.

Mt Sinai J Med. 2004 Oct;71(5):344-6.

PMID:
15543436

Supplemental Content

Loading ...
Support Center